zyvran pharmaceuticals

Zyvran Pharmaceuticals is a clinical-stage biopharmaceutical company headquartered in Los Angeles, California, specializing in the repurposing of FDA-approved drugs for the treatment of complex central nervous system (CNS) and neurological disorders. The company's lead programs target high-unmet-need indications such as dementia, treatment-resistant depression, chronic pain, and autism spectrum disorders. Zyvran utilizes a unique combination drug strategy designed to induce neuroplastic effects and improve therapeutic outcomes while leveraging the established safety profiles of existing molecules to accelerate development. Led by founder and CEO Dr. Taghogho Agarin, the company has presented its innovative approach at major industry events, including the Biotech Showcase and LSX Congress.